Long-term micronutrient and amino acid supplementation increases embryo recovery per flush and ovarian responsiveness in donor mares.

This study found that donor mares given a daily multinutrient and amino acid supplement for several months produced more embryos per uterine flush and showed greater ovarian follicular activity than when they were on a basal diet. The number and size of follicles increased with supplementation, while embryo quality grades were similar between supplemented and control phases.

What question did the study address?

• Whether long-term micronutrient plus amino acid supplementation increases embryo recovery per flush and improves ovarian responsiveness in donor mares used for embryo transfer programs.

Why this matters

• Embryo transfer efficiency in mares depends on consistent ovulation and retrieval of viable embryos; modest improvements per flush can meaningfully raise season-long yield.
• Nutritional modulation of folliculogenesis and oocyte competence is biologically plausible, but field evidence with sustained, multi-month supplementation has been limited.

Study design and population

• Design: Crossover trial across two consecutive breeding seasons with a 6-month washout between phases.
• Animals: 12 multiparous, non-lactating crossbred donor mares aged 4–12 years.
• Cycles/flushes: 115 total uterine flushes (60 during supplementation; 55 during control diet).
• Crossover strength: Each mare served as her own control, helping control for between-mare variability in fertility and ovarian dynamics.

Intervention and control

• Control: Basal diet typical for the facility.
• Intervention: Basal diet plus a multinutrient supplement with amino acids at 40 g/day for 150 days (about five months).
• Washout: 6 months between phases to minimize carryover effects.
• Supplement composition: Not detailed in the abstract; described broadly as a micronutrient and amino acid blend.

Reproductive management and outcome assessment

• Monitoring: Transrectal ultrasonography to track follicular development.
• Ovulation induction: Triggered when preovulatory criteria were met; fixed-time artificial insemination with frozen semen was performed 24 hours after induction.
• Ovulation verification: Assessed 48 hours after induction; if not yet ovulated, mares were checked every 12 hours until ovulation occurred.
• Timing reference: Day 0 defined as the first day ovulation was detected and used to schedule embryo recovery.
• Primary outcome: Embryo recovery rate per uterine flush.
• Secondary outcomes: Mare-level counts of small follicles (≤15 mm) and large follicles (≥30 mm); embryo morphology-based quality grades.

Main findings

• Embryo recovery per flush:
  • Supplemented: 49/60 flushes (81.7%).
  • Control: 36/55 flushes (65.4%).
  • Absolute difference: +16.2 percentage points (95% CI 0.3 to 32.1; P = 0.048).
• Ovarian responsiveness (mare-level follicle counts across the observation period):
  • Small follicles (≤15 mm): 115.3 ± 10.3 with supplementation vs 112.7 ± 11.0 during control (P = 0.003).
  • Large follicles (≥30 mm): 24.7 ± 3.1 with supplementation vs 23.1 ± 2.9 during control (P = 0.012).
• Embryo quality:
  • Distribution of morphology-based grades was similar between phases, indicating more embryos recovered but without a shift in quality grading.

How to interpret the effect size

• Relative improvement: Approximately 25% higher embryo recovery rate with supplementation (risk ratio ≈ 1.25).
• Clinical yield: About 1 additional embryo per ~6 flushes with supplementation (number needed to treat ≈ 6; based on the absolute difference of 0.162).
• Statistical note: The confidence interval barely excludes zero and P = 0.048, so the result meets conventional significance but suggests the true benefit could range from small to substantial.

Biological plausibility

• Micronutrients and amino acids support:
  • Folliculogenesis and steroidogenesis (e.g., via cofactors for enzymatic pathways involved in hormone synthesis).
  • Oocyte and follicular cell redox balance, potentially mitigating oxidative stress that can impair oocyte competence.
  • Granulosa/theca cell proliferation and responsiveness to gonadotropins, reflected here by increased counts of small and large follicles.
• The unchanged embryo grade distribution suggests the primary effect may be on the quantity of transferable embryos rather than detectable morphology-based quality.

Strengths

• Crossover design with each mare acting as her own control reduces confounding from inherent fertility differences.
• Extended supplementation period (150 days) captures long-term nutritional effects across multiple follicular waves.
• Standardized reproductive management (ultrasound monitoring, ovulation induction, fixed-time AI, defined Day 0) limits protocol-related variability.

Limitations and cautions

• Sample size: Only 12 mares; results are based on repeated measures and may have limited generalizability.
• Borderline statistical significance for the primary outcome (P = 0.048); magnitude of benefit remains uncertain (wide CI).
• Supplement composition not specified; replication and translation require clarity on ingredients and doses.
• Carryover and period effects: A 6-month washout was used, but seasonality or order effects cannot be fully excluded.
• Population specificity: Multiparous, non-lactating crossbred mares; effects may differ in maiden, lactating, aged, or different-breed mares.
• Outcome scope: Embryo recovery and morphology were assessed; downstream pregnancy and foaling outcomes were not reported in the abstract.

Practical implications

• For embryo transfer programs, adding a defined multinutrient plus amino acid supplement months in advance may increase embryos recovered per flush without compromising morphological quality.
• Planning: Benefits emerged with long-term administration (about five months), so start well before the breeding season.
• Management remains crucial: Ultrasound-guided timing, ovulation induction, and AI protocol standardization are still key determinants of success.
• Monitor: Track follicular dynamics and embryo recovery rates within a program to confirm benefit with the specific supplement used.

What remains unknown and future directions

• Which specific micronutrients and amino acids drive the effect, and the optimal dosing/time course.
• Impacts on pregnancy establishment, embryo survival post-transfer, and foaling rates.
• Efficacy in other mare categories (e.g., older, lactating, subfertile) and under different semen types or AI timing strategies.
• Cost-effectiveness analyses balancing supplement costs against increased embryo yield.

Bottom line

• Long-term multinutrient and amino acid supplementation was associated with a higher embryo recovery rate per flush and greater ovarian follicular activity in donor mares, with no change in embryo morphology grades. The effect appears clinically meaningful but modest, and confirmation with larger, composition-defined studies is warranted.